EUVIMEDEUVIMED entdecken
Crossref

Administration of serotonin and norepinephrine reuptake inhibitors tends to have less ocular surface damage in a chronic stress-induced rat model of depression than selective serotonin reuptake inhibitors

Han Zhao, Yue Yin, Tong Lin, Wushuang Wang, Lan Gong

Experimental Eye Research · 2023

DOI: 10.1016/j.exer.2023.109486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2023. Verfasst von Han Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye, Ear, Nose, and Throat Hospital of Fudan University, Shanghai, 200000, China; Laboratory of Myopia, NHC Key Laborato…. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depressed patients who medicate with selective serotonin reuptake inhibitors (SSRIs) often report ocular dryness. Epidemiological studies have found that serotonin and norepinephrine reuptake inhibitors (SNRIs) are not risk factors for dry eye in depressed patients. However, the effect of SNRIs on the ocular surface is unknown. A depression rat model was induced by chronic unpredictable mild stress (CUMS), and SNRIs or SSRIs were administered to the rats for 3 or 6 weeks. The levels of norepinephrine (NE) and serotonin in tear fluid were tested by ELISA. The corneal fluorescence and lissamine green staining were used to evaluate ocular surface damage. NE and/or serotonin were administered to human corneal epithelial cells in vitro. RNA sequencing (RNA-seq) analysis was performed to investigate the mRNA expression profiles. Tear NE levels were higher in the SNRIs group, and ocular surface inflammation and apoptosis were significantly reduced compared to the SSRIs group. RNA-Seq indicated that NE significantly activate MAPK signaling pathway. NE can inhibit serotonin-induced activation of the NF-κB signaling pathway through α-1 adrenergic receptors and promotes the proliferation of corneal epithelial cells through activation of the MAPK signaling pathway. SNRIs administration have less ocular surface damage than SSRIs. NE protects human corneal epithelial cells from damage, and reduce inflammation on the ocular surface via activating the MAPK signaling pathway. SNRIs might be used as an appropriate treatment for depression-related DED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Selective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake InhibitorsHumansRatsAnimalsSerotoninDepressionNorepinephrine

Stichwörter der Autor:innen

DepressionDry eye diseaseNorepinephrineSNRIs

Substanzen

Selective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake InhibitorsSerotoninNorepinephrine

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye, Ear, Nose, and Throat Hospital of Fudan University, Shanghai, 200000, China; Laboratory of Myopia, NHC Key Laboratory of Myopia (Fudan University), Chinese Academy of Medical Sciences,…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, H., Yin, Y., Lin, T., Wang, W., & Gong, L. (2023). Administration of serotonin and norepinephrine reuptake inhibitors tends to have less ocular surface damage in a chronic stress-induced rat model of depression than selective serotonin reuptake inhibitors. Experimental Eye Research. https://doi.org/10.1016/j.exer.2023.109486

Vancouver

Zhao H, Yin Y, Lin T, Wang W, Gong L. Administration of serotonin and norepinephrine reuptake inhibitors tends to have less ocular surface damage in a chronic stress-induced rat model of depression than selective serotonin reuptake inhibitors. Experimental Eye Research. 2023. doi:10.1016/j.exer.2023.109486

BibTeX
@article{Zhao2023,
  author = {Zhao, Han and Yin, Yue and Lin, Tong and Wang, Wushuang and Gong, Lan},
  title = {Administration of serotonin and norepinephrine reuptake inhibitors tends to have less ocular surface damage in a chronic stress-induced rat model of depression than selective serotonin reuptake inhibitors},
  journal = {Experimental Eye Research},
  year = {2023},
  doi = {10.1016/j.exer.2023.109486}
}
Kostenlos starten →